Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 13644 | 759 | 28.0 | 77% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 39 | 32196 | MANTLE CELL LYMPHOMA//MYCOSIS FUNGOIDES//DIFFUSE LARGE B CELL LYMPHOMA |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | CUTANEOUS B CELL LYMPHOMA | Author keyword | 56 | 68% | 7% | 50 |
| 2 | PRIMARY CUTANEOUS B CELL LYMPHOMA | Author keyword | 47 | 81% | 4% | 29 |
| 3 | CUTANEOUS LYMPHOID HYPERPLASIA | Author keyword | 21 | 71% | 2% | 17 |
| 4 | PRIMARY CUTANEOUS FOLLICLE CENTER LYMPHOMA | Author keyword | 21 | 90% | 1% | 9 |
| 5 | CUTANEOUS LYMPHOMA | Author keyword | 17 | 23% | 9% | 66 |
| 6 | PRIMARY CUTANEOUS MARGINAL ZONE B CELL LYMPHOMA | Author keyword | 15 | 88% | 1% | 7 |
| 7 | PRIMARY CUTANEOUS B CELL LYMPHOMAS | Author keyword | 12 | 86% | 1% | 6 |
| 8 | CUTANEOUS B CELL LYMPHOMAS | Author keyword | 11 | 78% | 1% | 7 |
| 9 | PRIMARY CUTANEOUS MARGINAL ZONE LYMPHOMA | Author keyword | 8 | 75% | 1% | 6 |
| 10 | PSEUDOLYMPHOMATOUS FOLLICULITIS | Author keyword | 8 | 75% | 1% | 6 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | WHO EORTC CLASSIFICATION | 53 | 55% | 9% | 66 |
| 2 | EORTC CLASSIFICATION | 33 | 40% | 9% | 66 |
| 3 | TREATMENT OF CANCER | 27 | 30% | 10% | 76 |
| 4 | LEG TYPE | 15 | 63% | 2% | 15 |
| 5 | NEOPLASMS REAL | 11 | 100% | 1% | 6 |
| 6 | BCL 2 PROTEIN EXPRESSION | 9 | 18% | 6% | 44 |
| 7 | PSEUDOLYMPHOMAS | 7 | 53% | 1% | 10 |
| 8 | LYMPHADENOSIS BENIGNA CUTIS | 6 | 44% | 1% | 11 |
| 9 | SARCOMATOID VARIANT | 5 | 60% | 1% | 6 |
| 10 | LYMPHOCYTOMA CUTIS | 5 | 43% | 1% | 9 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas | 2008 | 100 | 97 | 80% |
| Primary cutaneous B-cell lymphoma: classification and treatment | 2006 | 34 | 55 | 75% |
| Primary cutaneous marginal zone lymphoma | 2010 | 12 | 66 | 56% |
| Primary Cutaneous Marginal Zone Lymphoma in Children: A Report of 3 Cases and Review of the Literature | 2014 | 3 | 25 | 44% |
| The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants | 2005 | 74 | 19 | 58% |
| Recent advances in primary cutaneous B-cell lymphomas | 2014 | 1 | 42 | 83% |
| Two Pediatric Cases of Primary Cutaneous B-cell Lymphoma and Review of the Literature | 2009 | 6 | 20 | 70% |
| Radiotherapy of primary cutaneous follicle center lymphoma: case report and review of literature | 2013 | 1 | 62 | 84% |
| Primary cutaneous B-cell lymphoma: Review and current concepts | 2000 | 62 | 96 | 59% |
| A review of 55 cases of cutaneous lymphoid hyperplasia: reassessment of the histopathotogic findings leading to reclassification of 4 lesions as cutaneous marginal zone lymphoma and 19 as pseudo lymphomatous folliculitis | 2005 | 34 | 14 | 64% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | DERMATOL CANCEROL | 1 | 33% | 0.3% | 2 |
| 2 | BRADFORD HOSP NHS FDN TRUST | 1 | 50% | 0.1% | 1 |
| 3 | CLIN PATHOLPHYSIOL | 1 | 50% | 0.1% | 1 |
| 4 | CUTANEOUS LYMPHOMA STUDY GRP | 1 | 50% | 0.1% | 1 |
| 5 | CUTANEOUS MUCOSAL PATHOPHYSIOL | 1 | 50% | 0.1% | 1 |
| 6 | DERMATOL SERV 11 GW | 1 | 50% | 0.1% | 1 |
| 7 | DERMATOL UNIT 1 | 1 | 50% | 0.1% | 1 |
| 8 | HOSP UNIV NUESTRA SENORA CANDELARIA | 1 | 50% | 0.1% | 1 |
| 9 | HP 6 | 1 | 50% | 0.1% | 1 |
| 10 | IMIMGRETNHE | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000241107 | MYCOSIS FUNGOIDES//CUTANEOUS T CELL LYMPHOMA//SEZARY SYNDROME |
| 2 | 0.0000129940 | ANAPLASTIC LARGE CELL LYMPHOMA//LYMPHOMATOID PAPULOSIS//NPM ALK |
| 3 | 0.0000115020 | LYMPH NODE INFARCTION//HEMATOPOIETIC DIFFERENTIATION ANTIGENS//MACROPHAGE ASSOCIATED ANTIBODIES |
| 4 | 0.0000104822 | BIOMED 2//TREPHINE BIOPSY//BONE MARROW BIOPSY |
| 5 | 0.0000097079 | ISOTOPIC RESPONSE//IMMUNOCOMPROMISED DISTRICT//RENBOK PHENOMENON |
| 6 | 0.0000091034 | SUBCUTANEOUS PANNICULITIS LIKE T CELL LYMPHOMA//HEPATOSPLENIC GAMMA DELTA T CELL LYMPHOMA//WEBER CHRISTIAN DISEASE |
| 7 | 0.0000073416 | SPLENIC MARGINAL ZONE LYMPHOMA//NODAL MARGINAL ZONE LYMPHOMA//MONOCYTOID B CELL LYMPHOMA |
| 8 | 0.0000068352 | DIFFUSE LARGE B CELL LYMPHOMA//PRIMARY MEDIASTINAL LARGE B CELL LYMPHOMA//GRAY ZONE LYMPHOMA |
| 9 | 0.0000066128 | MALT LYMPHOMA//GASTRIC LYMPHOMA//GASTRIC MALT LYMPHOMA |
| 10 | 0.0000059758 | ANGIOIMMUNOBLASTIC T CELL LYMPHOMA//PERIPHERAL T CELL LYMPHOMA//ANGIOIMMUNOBLASTIC LYMPHOMA |